[
    {
        "title": "Travere Therapeutics just misses on confirmatory study for kidney ... - Endpoints News",
        "description": "Travere Therapeutics just misses on confirmatory study for kidney ...  Endpoints News",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vZW5kcHRzLmNvbS90cmF2ZXJlLXRoZXJhcGV1dGljcy1qdXN0LW1pc3Nlcy1vbi1jb25maXJtYXRvcnktc3R1ZHktZm9yLWtpZG5leS1kaXNlYXNlLWRydWctc3RvY2stcGx1bW1ldHMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint ... - BioSpace",
        "description": "Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint ...  BioSpace",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RyYXZlcmUtcy1raWRuZXktZGlzZWFzZS1kcnVnLW5hcnJvd2x5LW1pc3Nlcy1waGFzZS1paWktZW5kcG9pbnQtc3RvY2stdGFua3Mv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Travere's Filspari misses the mark in rare kidney disease trial - FiercePharma",
        "description": "Travere's Filspari misses the mark in rare kidney disease trial  FiercePharma",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RyYXZlcmVzLWZpbHNwYXJpLW1pc3Nlcy1raWRuZXktZGlzZWFzZS10cmlhbC1yZW1vdmFsLW1hcmtldC1sb29rcy11bmxpa2VseS1hbmFseXN0c9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]